Salim Yazji - Apr 12, 2023 Form 4 Insider Report for Oncternal Therapeutics, Inc. (ONCT)

Role
Chief Medical Officer
Signature
/s/Chase C. Leavitt, Attorney-in-fact
Stock symbol
ONCT
Transactions as of
Apr 12, 2023
Transactions value $
$7,200
Form type
4
Date filed
4/14/2023, 06:02 PM
Previous filing
Feb 23, 2023
Next filing
Jul 5, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ONCT Common Stock Purchase $2.85K +10K +7.16% $0.29 150K Apr 12, 2023 Direct
transaction ONCT Common Stock Purchase $2.85K +10K +6.68% $0.29 160K Apr 13, 2023 Direct
transaction ONCT Common Stock Purchase $1.5K +5K +3.13% $0.30 165K Apr 14, 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.